Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionBerkeley Capital Partners, LLC
Latest Disclosed Ownership2,053 shares
Latest Disclosed Value $ 286,127
Berkeley Capital Partners, LLC reports 2.29% increase in ownership of GILD / Gilead Sciences, Inc.

On May 6, 2026 - Berkeley Capital Partners, LLC filed a 13F-HR form disclosing ownership of 2,053 shares of Gilead Sciences, Inc. (CH:GILD) valued at $286,127 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 2,007 shares of Gilead Sciences, Inc.. This represents a change in shares of 2.29% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,053 46 2.29 286 16.26 0.0663
2026-02-05 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,007 -16 -0.79 246 9.82 0.0580
2025-11-10 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,023 139 7.38 225 7.69 0.0531
2025-07-30 2025-06-30 13F GILEAD SCIENCES COM 375558103 1,884 5 0.27 209 -0.95 0.0530
2025-05-05 2025-03-31 13F GILEAD SCIENCES COM 375558103 1,879 1,879 211 0.0579
2020-11-03 2020-09-30 13F GILEAD SCIENCES COM 375558103 0 -7,545 -100.00 0 -100.00
2020-07-30 2020-06-30 13F GILEAD SCIENCES COM 375558103 7,545 -3,132 -29.33 580 -27.32 0.3573
2020-04-21 2020-03-31 13F GILEAD SCIENCES COM 375558103 10,677 10,677 798 0.5421
2016-05-11 2016-03-31 13F GILEAD SCIENCES COM 375558103 0 -2,954 -100.00 0 -100.00
2016-05-11 2015-12-31 13F GILEAD SCIENCES COM 375558103 2,954 2,954 299 0.2430
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.